Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges Telomir Pharmaceuticals Q4 2025 Earnings EPS Misses Wide Estimate as Development Costs Mount QuinStreet Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gains Chime Financial Inc CHYM Q1 2026 Earnings Robust EPS Beat Defies Market Skepticism IMMR Q3 2025 Earnings EPS Surges Past Estimates Stock Rises on Strong Licensing Performance FUFU Q4 2025 Earnings Massive EPS Miss Underscores Bitcoin Mining Headwinds